Previous symbols: NEUROD. Aliases: BETA2, BHF-1, NeuroD, bHLHa3, MODY6.
NEUROD1 (Neurogenic differentiation factor 1, also known as NeuroD, NeuroD1, BETA2, or BHLHA3) is a Group A basic helix-loop-helix (bHLH) transcription factor with dual essential roles in neuronal and pancreatic endocrine development. The protein functions in the nucleus where it binds E-box motifs (CANNTG) to activate lineage-specific transcriptional programs. NEUROD1 heterodimerizes with class I bHLH E proteins (e.g., TCF12/E2-2, E47) and cooperates with lineage-specific transcription factors to regulate chromatin accessibility and gene expression. In the nervous system, NEUROD1 is essential for neuronal survival, differentiation, and maturation in multiple regions including hippocampus and inner ear, directly activating neural genes such as Pou3f2, Insm1, Nhlh1, Atoh1, Neurod4, and Nhlh2. In the pancreas, NEUROD1 is critical for endocrine differentiation and β-cell development, supporting expression of key β-cell transcription factors (MAFA, NKX6-1, PDX1, INSM1, NKX2-2, ISL1, PAX6, RFX6) and insulin gene transcription. Human NEUROD1 mutations cause MODY6 diabetes. NEUROD1 can act as a pioneer-like factor in context-dependent manner and is widely used in cellular reprogramming protocols. NEUROD1-high expression defines a molecular subtype of small cell lung cancer.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Diabetes mellitus | causative |
mechanism: Monogenic Beta-Cell Dysfunction
subtype: maturity-onset diabetes of the young type 6
scoped to subtype: maturity-onset diabetes of the young type 6
|
| Olfactory Neuroblastoma | no genetic record |
mechanism: Retained Globose Basal Cell Transcriptional Programme
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| monogenic diabetes MONDO:0015967 | AD | Moderate 2026-02-23 |
Diabetes mellitus
causative
|
| monogenic diabetes MONDO:0015967 | AR | Moderate 2021-03-10 |
Diabetes mellitus
causative
|
Identity from HGNC (snapshot 2026-10-24). Page layers are described in the gene pages documentation.